ID   WSU-DLCL
AC   CVCL_M580
DR   ABM; T8232
DR   Cosmic; 1086347
DR   DSMZ; ACC-779
DR   DSMZCellDive; ACC-779
DR   Wikidata; Q54994466
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1540884;
RX   PubMed=8558920;
CC   Doubling time: 20 hours (PubMed=1540884); ~48-72 hours (DSMZ=ACC-779).
CC   Discontinued: BioIVT/Asterand Bioscience; Catalog number WSU-DLCL.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-779
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 14,17.2
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 18
ST   Penta D: 9,10
ST   Penta E: 11
ST   TH01: 8,9.3
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=1540884; DOI=10.1002/1097-0142(19920315)69:6<1468::AID-CNCR2820690626>3.0.CO;2-8;
RA   Mohammad R.M., Mohamed A.N., KuKuruga M., Smith M.R., Al-Katib A.;
RT   "A human B-cell lymphoma line with a de novo multidrug resistance
RT   phenotype.";
RL   Cancer 69:1468-1474(1992).
//
RX   PubMed=8558920;
RA   Dirks W.G., Zaborski M., Jager K., Challier C., Shiota M.,
RA   Quentmeier H., Drexler H.G.;
RT   "The (2;5)(p23;q35) translocation in cell lines derived from malignant
RT   lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.";
RL   Leukemia 10:142-149(1996).
//